Aspiriant LLC’s Vanguard California Tax-Exempt Bond ETF VTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$239K Hold
2,530
– – 0.01% 371
2026
Q2
$255K Hold
2,530
– – 0.01% 344
2026
Q1
$251K Hold
2,530
– – 0.01% 306
2025
Q4
$254K Hold
2,530
– – 0.01% 293
2025
Q3
$252K Hold
2,530
– – 0.01% 272
2025
Q2
$247K Buy
2,530
+30
+1% +$2.91K 0.01% 281
2025
Q1
$246K Buy
2,500
+30
+1% +$2.98K 0.01% 264
2024
Q4
$246K Buy
+2,470
New +$248K 0.01% 256

Other funds holding VTEC

Aspiriant LLC's VTEC Position: Q3 2026 in Review

Aspiriant LLC held its Vanguard California Tax-Exempt Bond ETF (VTEC) position steady in Q3 2026 at 2,530 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #371.

Aspiriant LLC first reported a position in VTEC in Q4 2024 and has held it in 8 quarters since. The position peaked at $255K in Q2 2026. 65 funds tracked by Wall St. Rank hold VTEC as of Q3 2026.

  • Aspiriant LLC held 2,530 shares of Vanguard California Tax-Exempt Bond ETF worth $239K as of Q3 2026.
  • Aspiriant LLC left its Vanguard California Tax-Exempt Bond ETF share count unchanged in Q3 2026.
  • Vanguard California Tax-Exempt Bond ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #371 holding.
  • Aspiriant LLC first reported a position in Vanguard California Tax-Exempt Bond ETF in Q4 2024 and has held it in 8 quarters since.
  • Aspiriant LLC's Vanguard California Tax-Exempt Bond ETF position peaked at $255K in Q2 2026.
  • 65 funds tracked by Wall St. Rank held Vanguard California Tax-Exempt Bond ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.